Chromatin accessibility derived from cfDNA serves as a novel classification biomarker of glioma
In conclusion, our study defines novel chromatin-accessibility-based biomarkers and illustrates their potential application in glioma liquid biopsy.
Authors
- Ying Han (ORCID: https://orcid.org/0000-0002-1791-6870)
- Min Chen (ORCID: https://orcid.org/0000-0002-9502-7681)
- Hao Pan (ORCID: https://orcid.org/0000-0001-9925-0752)
- Qiuyue Wu
- Fan Wang (ORCID: https://orcid.org/0000-0002-6296-402X)
- Yang Yang (ORCID: https://orcid.org/0000-0002-9008-5137)
- Jian Wu (ORCID: https://orcid.org/0000-0002-3394-1507)
- Qiang Wang (ORCID: https://orcid.org/0000-0002-7941-880X)
- Lan Luo
- Wei Dai (ORCID: https://orcid.org/0000-0002-3526-5899)
- Xinyi Xia (ORCID: https://orcid.org/0000-0002-4666-9303)
- Chen‐Yu Zhang (ORCID: https://orcid.org/0000-0002-7329-7162)
Institutions
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Jinling Institute of Technology (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-12-15
- DOI
- https://doi.org/10.3389/fonc.2025.1688625
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province